Loading...

TNYA TENAYA THERAPEUTICS INC Delisting Actions 8-K Filing

TNY

TNY

TENAYA THERAPEUTICS INC

(TNYA)

2026 8-K

Financial Results Announcement

Financial Results Announcement

Collaboration Agreement

NASDAQ Compliance Notice

Director Resignation

Public Offering Announcement

FDA Approval Update

Financial Results Report

FDA Clinical Hold

Financial Statements

Financial Statements

Nasdaq Compliance

Restructuring Plan

Earnings Announcement

Public Offering

Management Changes

Stock Option Repricing

Clinical Trial Update

Management Change

Earnings Announcement

Financial Results and Manag...

Resignation of CFBO

Resignation of Director

Annual Meeting and Voting R...

Financial Results and Workf...

Earnings Reports

Underwriting Agreement for ...

Earnings Reports

Earnings Reports

Amendments to Executive Sev...

Earnings Reports

Amended and Restated Bylaws

Regulation FD Disclosure

Earnings Reports

External Links:

Tenaya Therapeutics, Inc. reported on January 26, 2026, that it failed to meet NASDAQ's minimum bid price requirement of $1.00 per share, and has a compliance period until July 27, 2026, to regain compliance. The company's stock remains listed while it works to meet this requirement.

AI Assistant

TENAYA THERAPEUTICS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.